News Archive

2015

September

Media Release / Sep 18, 2015

Swissmedic approves Novartis' new heart failure medicine Entresto(TM)

Read More
Media Release / Sep 07, 2015

Novartis Foundation healthcare models and disease elimination programs showcased at ECTMIH

Read More
Media Release / Sep 04, 2015

Novartis receives EU approval for Farydak®, the first in its class of anticancer agents approved for patients with multiple myeloma

Read More
Media Release / Sep 03, 2015

Sandoz launches ZarxioTM (filgrastim-sndz), the first biosimilar in the United States

Read More
Media Release / Sep 02, 2015

Novartis receives EU approval for new Revolade® use as first-in-class therapy for patients with severe aplastic anemia

Read More
Media Release / Sep 01, 2015

Novartis announces global partnership with Amgen to develop and commercialize pioneering neuroscience treatments

Read More
Media Release / Sep 01, 2015

Novartis receives EU approval for Tafinlar® and Mekinist®, first combination approved for patients with aggressive form of melanoma

Read More

August

Media Release / Aug 28, 2015

Novartis continues commitment to go the last mile in effort to eliminate leprosy

Read More
Media Release / Aug 27, 2015

Novartis International BioCamp highlights how collaboration and diversity drive innovation and inspires future science leaders

Read More
Media Release / Aug 24, 2015

FDA expands use of Novartis drug Promacta® to include treatment of children ages 1 and older with chronic immune thrombocytopenia

Read More

Pages